Commensal Streptococcus agalactiae isolated from patients seen at University Hospital of Londrina, Paraná, Brazil: Capsular types, genotyping, antimicrobial susceptibility and virulence determinants

BMC Microbiology

Volumn 13, Issue 1, 2013, Pages

  Otaguiri, Eliane Saori ^a   Morguette, Ana Elisa Belotto ^a   Tavares, Eliandro Reis ^a   Dos Santos, Pollyanna Myrella Capela ^a   Morey, Alexandre Tadachi ^a   Cardoso, Juscélio Donizete ^a   Perugini, Márcia Regina Eches ^a   Yamauchi, Lucy Megumi ^a   Yamada Ogatta, Sueli Fumie ^a  

^a STATE UNIVERSITY OF LONDRINA   (Brazil)

Author keywords

Capsular antigen; Erythromycin, Clindamycin, MLVA typing; Group B Streptococcus; pilus island, Virulence traits

Indexed keywords

AMPICILLIN; CAROTENOID; CEFEPIME; CEFOTAXIME; CHLORAMPHENICOL; ERYTHROMYCIN; LEVOFLOXACIN; LINCOSAMIDE; MACROLIDE; PENICILLIN DERIVATIVE; STREPTOGRAMIN DERIVATIVE; VANCOMYCIN;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIAL VIRULENCE; BACTERIUM ISOLATE; BRAZIL; CONTROLLED STUDY; FEMALE; GENE LOCUS; GENOTYPE; HEMOLYSIS; HUMAN; IN VITRO STUDY; MAJOR CLINICAL STUDY; NONHUMAN; PHENOTYPE; STREPTOCOCCUS AGALACTIAE; STREPTOCOCCUS INFECTION; VARIABLE NUMBER OF TANDEM REPEAT;

BACTERIA (MICROORGANISMS); STREPTOCOCCUS AGALACTIAE; STREPTOCOCCUS SP. 'GROUP B';

ADOLESCENT; ADULT; ANTI-BACTERIAL AGENTS; BRAZIL; DRUG RESISTANCE, BACTERIAL; FEMALE; GENOTYPE; HOSPITALS, UNIVERSITY; HUMANS; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; MINISATELLITE REPEATS; MOLECULAR TYPING; SEROTYPING; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS AGALACTIAE; SYMBIOSIS; VIRULENCE FACTORS; YOUNG ADULT;

EID: 84890473164     PISSN: None     EISSN: 14712180     Source Type: Journal    
DOI: 10.1186/1471-2180-13-297     Document Type: Article

References (46)

1. A complete audit cycle of intrapartum group B streptococcus prophylaxis. McCord N, Owen P, Powls A, Lunan B, Health Bull (Edinb) 2001 59 263 267 12664737
2. Maternal peripartum complications associated with vaginal group B streptococci colonization. Krohn MA, Hillier SL, Baker CJ, J Infect Dis 1999 179 1410 1415 10.1086/314756 10228062 (Pubitemid 29246590)
3. Epidemiology of invasive group B streptococcal disease in the United States, 1999-2005. Phares CR, Lynfield R, Farley MM, Mohle-Boetani J, Harrison LH, Petit S, Craig AS, Schaffner W, Zansky SM, Gershman K, et al. JAMA 2008 299 2056 2065 10.1001/jama.299.17.2056 18460666 (Pubitemid 351656587)
4. Group B streptococcal disease in newborns: A global perspective on prevention. Schuchat A, Biomed Pharmacother 1995 49 19 25 10.1016/0753-3322(96) 82573-X 7749075
5. Group B streptococcal disease in infants: Progress in prevention and continued challenges. Verani JR, Schrag SJ, Clin Perinatol 2010 37 375 392 10.1016/j.clp.2010.02.002 20569813
6. Prevention of perinatal group B streptococcal disease-revised guidelines from CDC, 2010. Verani JR, McGee L, Schrag SJ, MMWR Recomm Rep 2010 59 1 36
7. Group B streptococcal disease in infants aged younger than 3 months: Systematic review and meta-analysis. Edmond KM, Kortsalioudaki C, Scott S, Schrag SJ, Zaidi AK, Cousens S, Heath PT, Lancet 2012 379 547 556 10.1016/S0140-6736(11)61651-6 22226047
8. Group B streptococcal infections in elderly adults. Edwards MS, Baker CJ, Clin Infect Dis 2005 41 839 847 10.1086/432804 16107984 (Pubitemid 41266752)
9. Increasing burden of invasive group B streptococcal disease in nonpregnant adults, 1990-2007. Skoff TH, Farley MM, Petit S, Craig AS, Schaffner W, Gershman K, Harrison LH, Lynfield R, Mohle-Boetani J, Zansky S, et al. Clin Infect Dis 2009 49 85 92 10.1086/599369 19480572
10. Distribution of antimicrobial resistance and virulence-related genes among Brazilian group B streptococci recovered from bovine and human sources. Duarte RS, Bellei BC, Miranda OP, Brito MA, Teixeira LM, Antimicrob Agents Chemother 2005 49 97 103 10.1128/AAC.49.1.97-103.2005 15616281 (Pubitemid 40065778)
11. Phenotypic and genotypic characterization of group B streptococcal isolates in southern Brazil. Palmeiro JK, Dalla-Costa LM, Fracalanzza SE, Botelho AC, da Silva Nogueira K, Scheffer MC, de Almeida Torres RS, de Carvalho NS, Cogo LL, Madeira HM, J Clin Microbiol 2010 48 4397 4403 10.1128/JCM.00419-10 20881175
12. The genetic diversity and phenotypic characterisation of Streptococcus agalactiae isolates from Rio de Janeiro, Brazil. Correa AB, Silva LG, Pinto Tde C, Oliveira IC, Fernandes FG, Costa NS, Mattos MC, Fracalanzza SE, Benchetrit LC, Mem Inst Oswaldo Cruz 2011 106 1002 1006 10.1590/S0074-02762011000800017 22241124
13. Antimicrobial resistance profiles and genetic characterisation of macrolide resistant isolates of Streptococcus agalactiae. Nakamura PA, Schuab RBB, Neves FP, Pereira CF, Paula GR, Barros RR, Mem Inst Oswaldo Cruz 2011 106 119 122 10.1590/S0074-02762011000200001 21537668
14. Nosocomial spread of multidrug-resistant group B streptococci with reduced penicillin susceptibility belonging to clonal complex 1. Nagano N, Nagano Y, Toyama M, Kimura K, Tamura T, Shibayama K, Arakawa Y, J Antimicrob Chemother 2012 67 849 856 10.1093/jac/dkr546 22210756
15. Antibiotic resistance patterns among group B Streptococcus isolates: Implications for antibiotic prophylaxis for early-onset neonatal sepsis. Capanna F, Emonet SP, Cherkaoui A, Irion OP, Schrenzel J, MartinezdeTejada B, Swiss Med Wkly 2013 143 0
16. Mechanisms of resistance to macrolides and lincosamides: Nature of the resistance elements and their clinical implications. Leclercq R, Clin Infect Dis 2002 34 482 492 10.1086/324626 11797175 (Pubitemid 34112269)
17. Molecular cloning and functional analysis of a novel macrolide-resistance determinant, mefA, from Streptococcus pyogenes. Clancy J, Petitpas J, Dib-Hajj F, Yuan W, Cronan M, Kamath AV, Bergeron J, Retsema JA, Mol Microbiol 1996 22 867 879 10.1046/j.1365-2958.1996.01521.x 8971709 (Pubitemid 26411332)
18. Structural and genetic diversity of group B streptococcus capsular polysaccharides. Cieslewicz MJ, Chaffin D, Glusman G, Kasper D, Madan A, Rodrigues S, Fahey J, Wessels MR, Rubens CE, Infect Immun 2005 73 3096 3103 10.1128/IAI.73.5.3096-3103.2005 15845517 (Pubitemid 40570379)
19. Serotype IX, a Proposed New Streptococcus agalactiae Serotype. Slotved HC, Kong F, Lambertsen L, Sauer S, Gilbert GL, J Clin Microbiol 2007 45 2929 2936 10.1128/JCM.00117-07 17634306 (Pubitemid 47417336)
20. Capsular type and antibiotic resistance in Streptococcus agalactiae isolates from patients, ranging from newborns to the elderly, with invasive infections. Murayama SY, Seki C, Sakata H, Sunaoshi K, Nakayama E, Iwata S, Sunakawa K, Ubukata K, Antimicrob Agents Chemother 2009 53 2650 2653 10.1128/AAC.01716-08 19332682
21. Distribution of pilus islands of group B streptococcus associated with maternal colonization and invasive disease in South Africa. Madzivhandila M, Adrian PV, Cutland CL, Kuwanda L, Madhi SA, J Med Microbiol 2013 62 249 253 10.1099/jmm.0.052951-0 23065545
22. Prevention of C3 deposition by capsular polysaccharide is a virulence mechanism of type III group B streptococci. Marques MB, Kasper DL, Pangburn MK, Wessels MR, Infect Immun 1992 60 3986 3993 1398910
23. Genome analysis reveals pili in Group B Streptococcus. Lauer P, Rinaudo CD, Soriani M, Margarit I, Maione D, Rosini R, Taddei AR, Mora M, Rappuoli R, Grandi G, Telford JL, Science 2005 309 105 10.1126/science.1111563 15994549 (Pubitemid 40934983)
24. Role of pilus proteins in adherence and invasion of Streptococcus agalactiae to the lung and cervical epithelial cells. Sharma P, Lata H, Arya DK, Kashyap AK, Kumar H, Dua M, Ali A, Johri AK, J Biol Chem 2013 288 4023 4034 10.1074/jbc.M112.425728 23209289
25. Specific involvement of pilus type 2a in biofilm formation in group B Streptococcus. Rinaudo CD, Rosini R, Galeotti CL, Berti F, Necchi F, Reguzzi V, Ghezzo C, Telford JL, Grandi G, Maione D, PLoS One 2010 5 9216 10.1371/journal.pone.0009216 20169161
26. A group B streptococcal pilus protein promotes phagocyte resistance and systemic virulence. Maisey HC, Quach D, Hensler ME, Liu GY, Gallo RL, Nizet V, Doran KS, FASEB J 2008 22 1715 1724 10.1096/fj.07-093963 18198218 (Pubitemid 351811449)
27. Genetic basis for the beta-haemolytic/cytolytic activity of group B Streptococcus. Pritzlaff CA, Chang JC, Kuo SP, Tamura GS, Rubens CE, Nizet V, Mol Microbiol 2001 39 236 247 10.1046/j.1365-2958.2001.02211.x 11136446 (Pubitemid 32113498)
28. Group B streptococcal beta-hemolysin/cytolysin promotes invasion of human lung epithelial cells and the release of interleukin-8. Doran KS, Chang JC, Benoit VM, Eckmann L, Nizet V, J Infect Dis 2002 185 196 203 10.1086/338475 11807693 (Pubitemid 34056443)
29. Sword and shield: linked group B streptococcal beta-hemolysin/cytolysin and carotenoid pigment function to subvert host phagocyte defense. Liu GY, Doran KS, Lawrence T, Turkson N, Puliti M, Tissi L, Nizet V, Proc Natl Acad Sci U S A 2004 101 14491 14496 10.1073/pnas.0406143101 15381763 (Pubitemid 39346776)
30. Action pattern and substrate specificity of the hyaluronan lyase from group B streptococci. Baker JR, Pritchard DG, Biochem J 2000 348 Pt 2 465 471 10816443 (Pubitemid 30345222)
31. Carriage of Streptococcus agalactiae in women and neonates and distribution of serological types: a study in Brazil. Benchetrit LC, Fracalanzza SE, Peregrino H, Camelo AA, Sanches LA, J Clin Microbiol 1982 15 787 790 7047552 (Pubitemid 12109359)
32. A multi locus variable number of tandem repeat analysis (MLVA) scheme for Streptococcus agalactiae genotyping. Haguenoer E, Baty G, Pourcel C, Lartigue MF, Domelier AS, Rosenau A, Quentin R, Mereghetti L, Lanotte P, BMC Microbiol 2011 11 171 10.1186/1471-2180-11-171 21794143
33. Rapid multiple-locus variant-repeat assay (MLVA) for genotyping of Streptococcus agalactiae. Radtke A, Lindstedt BA, Afset JE, Bergh K, J Clin Microbiol 2010 48 2502 2508 10.1128/JCM.00234-10 20504982
34. Correlation of serotypes and genotypes of macrolide-resistant Streptococcus agalactiae. Uh Y, Kim HY, Jang IH, Hwang GY, Yoon KJ, Yonsei Med J 2005 46 480 483 10.3349/ymj.2005.46.4.480 16127771 (Pubitemid 41283057)
35. Identification of novel genomic islands coding for antigenic pilus-like structures in Streptococcus agalactiae. Rosini R, Rinaudo CD, Soriani M, Lauer P, Mora M, Maione D, Taddei A, Santi I, Ghezzo C, Brettoni C, et al. Mol Microbiol 2006 61 126 141 10.1111/j.1365-2958.2006.05225.x 16824100
36. Distribution of Pilus islands in streptococcus agalactiae that cause human infections: Insights into evolution and implication for vaccine development. Martins ER, Andreu A, Melo-Cristino J, Ramirez M, Clin Vaccine Immunol 2013 20 313 316 10.1128/CVI.00529-12 23269415
37. The putative glycosyltransferase-encoding gene cylJ and the group B Streptococcus (GBS)-specific gene cylK modulate hemolysin production and virulence of GBS. Forquin MP, Tazi A, Rosa-Fraile M, Poyart C, Trieu-Cuot P, Dramsi S, Infect Immun 2007 75 2063 2066 10.1128/IAI.01565-06 17283108 (Pubitemid 46559475)
38. Characterization and incidence of pigment production by human clinical group B streptococci. Merritt K, Jacobs NJ, J Clin Microbiol 1978 8 105 107 353069 (Pubitemid 8385532)
39. Association of elevated levels of extracellular neuraminidase with clinical isolates of type III group B streptococci. Milligan TW, Baker CJ, Straus DC, Mattingly SJ, Infect Immun 1978 21 738 746 361576 (Pubitemid 9011167)
40. Identification of a novel insertion element, IS1548, in group B streptococci, predominantly in strains causing endocarditis. Granlund M, Oberg L, Sellin M, Norgren M, J Infect Dis 1998 177 967 976 10.1086/515233 9534970 (Pubitemid 28155150)
41. CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Horan TC, Andrus M, Dudeck MA, Am J Infect Control 2008 36 309 332 10.1016/j.ajic.2008.03. 002 18538699 (Pubitemid 351763841)
42. Group B Streptococcus detection: comparison of PCR assay and culture as a screening method for pregnant women. de Paris F, Machado AB, Gheno TC, Ascoli BM, Oliveira KR, Barth AL, Braz J Infect Dis 2011 15 323 327 21861001
43. A multiplex PCR assay for the direct identification of the capsular type (Ia to IX) of Streptococcus agalactiae. Imperi M, Pataracchia M, Alfarone G, Baldassarri L, Orefici G, Creti R, J Microbiol Methods 2010 80 212 214 10.1016/j.mimet.2009.11.010 19958797
44. Numerical index of the discriminatory variability of typing systems: An application of Simpson's index of diversity. Hunter PR, Gaston MA, J Clin Microbiol 1988 26 2465 2466 3069867
45. CLSI, Performance standards for antimicrobial susceptibility testing. Twenty-second informational supplement (M100-S22) Wayne, PA: Clinical and Laboratory Standards Institute 2012
46. Three different phenotypes of erythromycin-resistant Streptococcus pyogenes in Finland. Seppala H, Nissinen A, Yu Q, Huovinen P, J Antimicrob Chemother 1993 32 885 891 10.1093/jac/32.6.885 8144429 (Pubitemid 24026589)